FI112777B - Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri - Google Patents

Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri Download PDF

Info

Publication number
FI112777B
FI112777B FI951086A FI951086A FI112777B FI 112777 B FI112777 B FI 112777B FI 951086 A FI951086 A FI 951086A FI 951086 A FI951086 A FI 951086A FI 112777 B FI112777 B FI 112777B
Authority
FI
Finland
Prior art keywords
acyclovir
water
ester
skin
salt
Prior art date
Application number
FI951086A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951086A (fi
FI951086A0 (fi
Inventor
Knud Erik Gebhard-Hansen
Soeren Bols Pedersen
Karen Bjoernsdottir
Bodil Gyllembourg Lissau
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of FI951086A publication Critical patent/FI951086A/fi
Publication of FI951086A0 publication Critical patent/FI951086A0/fi
Application granted granted Critical
Publication of FI112777B publication Critical patent/FI112777B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI951086A 1992-09-09 1995-03-08 Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri FI112777B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DK111392 1992-09-09
DK9300288 1993-09-09
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (3)

Publication Number Publication Date
FI951086A FI951086A (fi) 1995-03-08
FI951086A0 FI951086A0 (fi) 1995-03-08
FI112777B true FI112777B (fi) 2004-01-15

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951086A FI112777B (fi) 1992-09-09 1995-03-08 Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri

Country Status (27)

Country Link
EP (1) EP0662819B1 (de)
JP (1) JPH08501089A (de)
AT (1) ATE137113T1 (de)
AU (1) AU4945393A (de)
BG (1) BG62032B1 (de)
BR (1) BR9307024A (de)
CA (1) CA2142493A1 (de)
CZ (1) CZ284007B6 (de)
DE (1) DE69302396T2 (de)
DK (1) DK169121B1 (de)
EE (1) EE03088B1 (de)
ES (1) ES2086235T3 (de)
FI (1) FI112777B (de)
GR (1) GR3019984T3 (de)
HR (1) HRP931160B1 (de)
HU (1) HUT72606A (de)
LT (1) LT3056B (de)
LV (1) LV10912B (de)
NO (1) NO308234B1 (de)
PL (1) PL172663B1 (de)
RO (1) RO113306B1 (de)
RU (1) RU2128503C1 (de)
SI (1) SI9300469A (de)
SK (1) SK280119B6 (de)
UA (1) UA41897C2 (de)
WO (1) WO1994005258A1 (de)
ZA (1) ZA936661B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
AU2005235309B2 (en) * 2004-04-19 2012-07-26 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008006085A2 (en) * 2006-07-07 2008-01-10 University Of Washington Compositions and methods for predicting inhibitors of protein targets
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN114668851A (zh) 2010-12-29 2022-06-28 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
LT3056B (en) 1994-10-25
FI951086A (fi) 1995-03-08
UA41897C2 (uk) 2001-10-15
ATE137113T1 (de) 1996-05-15
RU2128503C1 (ru) 1999-04-10
LV10912B (en) 1996-08-20
DK169121B1 (da) 1994-08-22
AU4945393A (en) 1994-03-29
GR3019984T3 (en) 1996-08-31
SK29195A3 (en) 1997-01-08
CZ59995A3 (en) 1995-09-13
HUT72606A (en) 1996-05-28
SK280119B6 (sk) 1999-08-06
DE69302396D1 (de) 1996-05-30
BR9307024A (pt) 1999-06-29
RO113306B1 (ro) 1998-06-30
ES2086235T3 (es) 1996-06-16
EP0662819B1 (de) 1996-04-24
LTIP959A (en) 1994-05-15
CA2142493A1 (en) 1994-03-17
EE03088B1 (et) 1998-06-15
BG99484A (bg) 1995-12-29
NO950895L (no) 1995-03-08
JPH08501089A (ja) 1996-02-06
PL307860A1 (en) 1995-06-26
HU9500702D0 (en) 1995-04-28
FI951086A0 (fi) 1995-03-08
CZ284007B6 (cs) 1998-07-15
EP0662819A1 (de) 1995-07-19
BG62032B1 (bg) 1999-01-29
NO308234B1 (no) 2000-08-21
DK111392D0 (da) 1992-09-09
HRP931160A2 (en) 1995-12-31
DE69302396T2 (de) 1996-08-14
PL172663B1 (pl) 1997-10-31
SI9300469A (en) 1994-03-31
RU95110930A (ru) 1997-03-27
NO950895D0 (no) 1995-03-08
WO1994005258A1 (en) 1994-03-17
DK111392A (da) 1994-03-10
HRP931160B1 (en) 1999-04-30
ZA936661B (en) 1994-05-20
LV10912A (lv) 1995-12-20

Similar Documents

Publication Publication Date Title
FI112777B (fi) Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri
EP1073470B1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
CA1192496A (en) Topical pharmaceutical compositions
EP0677126B1 (de) Antivirale topische pharmazeutische zusammensetzungen
KR960001373B1 (ko) 제약학적 활성 물질의 침투 증강용 2성분계 침투증강 조성물
CA2170016C (en) Improved method for treating hair loss
JPS6036423A (ja) Ｎ−（２−ヒドロキシエチル）ピロリドンを含有する浸透局所製薬組成物
JP2007508261A (ja) 皮膚残留物を最小化するための経皮的医薬製剤
KR20070008690A (ko) 항콜린제를 위한 침투 강화 조성물
KR20070020139A (ko) 모발 성장 촉진용 제제
KR20100047840A (ko) 디클로페낙의 신규한 비수용성 국소 용액 및 이를 제조하는 과정
JP2555555B2 (ja) 抗真菌性外用製剤
JPH05178764A (ja) 局所用あるいは経皮用製品におけるジブチルアジペートとイソプロピルミリステートの用途
US11628177B2 (en) Compositions and methods for deep dermal drug delivery
KR950006217B1 (ko) 니코란딜 외용제
Aungst et al. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation‐enhancing vehicles
EP0535237A1 (de) Zusammensetzung zur linderung von hautirritationen sowie diese enthaltende externa zur transdermalen verabreichung
US5128135A (en) Percutaneous or trans-mucosal absorption enhancers, preparations containing the enhancers, and a method of preparing thereof
KR100866979B1 (ko) 이트라코나졸을 함유한 마이크로이멀젼계 하이드로겔 및이의 제조방법
JP2881836B2 (ja) 抗真菌剤
WO1991015210A1 (en) Compositions comprising cytotoxic agent and permeation enhancers
JPH05170640A (ja) 皮膚外用剤
ITMI972889A1 (it) Composizioni farmaceutiche per uso topico e/o transdermale